FGF-21 as a potential therapeutic target of NAFLD | TCRM - Dove Medical Press
The aim of this review is to critically summarize experimental and clinical data of fibroblast growth factor-21 in nonalcoholic fatty liver disease.
Introduction
Nonalcoholic fatty liver disease (NAFLD) has been closely associated with the metabolic syndrome (MetS); this has led to the recommendation of change in the disease nomenclature includi… [+56498 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
